focus -WSS

focus

author：knowledge 2025-09-14 10:04:28 - browse：93

Bob Kocher, a partner at venture capital firm Venrock, speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health.

“They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said. “If you’re sad, anxious, or depressed, why bother with people?”

Kocher, who is also a doctor and helped write the Affordable Care Act as an Obama administration health official, shared his thoughts on the biggest questions facing digital health at STAT’s Breakthrough Summit on Thursday. Besides sharing a peek inside his generative AI pitch-filled inbox, Kocher talked about cybersecurity vulnerabilities in health systems and venture capitalists buying hospitals.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Cherokee Nation medical school graduates its first class

WSS

Galapagos to make CAR

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Psychedelics group wrestles with new pharma identity

Senators push IRS to launch nonprofit hospital probe

Virginia high school admissions case could be legal follow

Novo Nordisk touts Wegovy study, but still struggling with supply

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Obesity drug from Roche shows promise in early study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Obesity drug from Roche shows promise in early study

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Be careful with at

Wikipedia

Galapagos to make CAR

Surge in Apellis stock fueled by confidence in safety of its eye drug

Galapagos to make CAR

Illinois Supreme Court finds assault weapons ban constitutional

Indictment alleges Trump's ex

STAT series 'Denied by AI' wins major journalism prizes

explore

focus

Wikipedia

hotspot